Cargando…

Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors

BACKGROUND: Inflammation in non‐small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2‐deoxy‐2‐[(18)F]fluoro‐D‐glucose positron emission tomography/computed tomography ([(18)F] FDG‐PET/CT) may be...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Alessio, Cantale, Ornella, Mogavero, Andrea, Garetto, Lucia, Racca, Manuela, Venesio, Tiziana, Anpalakhan, Shobana, Novello, Silvia, Gregorc, Vanesa, Banna, Giuseppe Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447168/
https://www.ncbi.nlm.nih.gov/pubmed/37442801
http://dx.doi.org/10.1111/1759-7714.15032
_version_ 1785094495766839296
author Rizzo, Alessio
Cantale, Ornella
Mogavero, Andrea
Garetto, Lucia
Racca, Manuela
Venesio, Tiziana
Anpalakhan, Shobana
Novello, Silvia
Gregorc, Vanesa
Banna, Giuseppe Luigi
author_facet Rizzo, Alessio
Cantale, Ornella
Mogavero, Andrea
Garetto, Lucia
Racca, Manuela
Venesio, Tiziana
Anpalakhan, Shobana
Novello, Silvia
Gregorc, Vanesa
Banna, Giuseppe Luigi
author_sort Rizzo, Alessio
collection PubMed
description BACKGROUND: Inflammation in non‐small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2‐deoxy‐2‐[(18)F]fluoro‐D‐glucose positron emission tomography/computed tomography ([(18)F] FDG‐PET/CT) may be used as a marker of inflammation by measuring glucose metabolism in different colonic sites. METHODS: This retrospective analysis aimed to investigate the correlation between [(18)F] FDGPET/CT SUV(ratio) in six gastrointestinal districts, the spleen, the pharynx and the larynx alongside the most avid tumor lesion with peripheral blood inflammatory indexes, including the neutrophil‐to‐lymphocyte ratio (NLR), systemic immune‐inflammatory index (SII, i.e., NLR times platelets) and lactate dehydrogenase (LDH), in patients with [(18)F] FDG‐PET/CT staged IV NSCLC who received first‐line immune checkpoint inhibitors (ICIs). The role of SUV(ratios) and peripheral blood inflammatory indexes in predicting overall survival (OS) and progression‐free survival (PFS) was then explored. RESULTS: A total of 43 patients were treated with first‐line ICI alone (58%) or in combination with chemotherapy (42%). A significant correlation was only found between the rectosigmoid SUV(ratio) and NLR (p = 0.0465). NLR >5.5 and LDH > 333.5 were associated with a worse OS (p = 0.033 and p = 0.009, respectively). The SII was associated with a worse PFS in patients treated with ICI alone (p = 0.033). None of the SUV(ratios) were significantly associated with OS or PFS, although a high left colon SUV(ratio) showed a trend toward a worse PFS. CONCLUSION: There was no significant correlation between [(18)F]FDG PET/CT uptake in different anatomical sites, and in the tumor, and systemic immune‐inflammatory indexes. The prognostic role of high left colon SUV(ratio) deserves further investigation.
format Online
Article
Text
id pubmed-10447168
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-104471682023-08-24 Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors Rizzo, Alessio Cantale, Ornella Mogavero, Andrea Garetto, Lucia Racca, Manuela Venesio, Tiziana Anpalakhan, Shobana Novello, Silvia Gregorc, Vanesa Banna, Giuseppe Luigi Thorac Cancer Original Articles BACKGROUND: Inflammation in non‐small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2‐deoxy‐2‐[(18)F]fluoro‐D‐glucose positron emission tomography/computed tomography ([(18)F] FDG‐PET/CT) may be used as a marker of inflammation by measuring glucose metabolism in different colonic sites. METHODS: This retrospective analysis aimed to investigate the correlation between [(18)F] FDGPET/CT SUV(ratio) in six gastrointestinal districts, the spleen, the pharynx and the larynx alongside the most avid tumor lesion with peripheral blood inflammatory indexes, including the neutrophil‐to‐lymphocyte ratio (NLR), systemic immune‐inflammatory index (SII, i.e., NLR times platelets) and lactate dehydrogenase (LDH), in patients with [(18)F] FDG‐PET/CT staged IV NSCLC who received first‐line immune checkpoint inhibitors (ICIs). The role of SUV(ratios) and peripheral blood inflammatory indexes in predicting overall survival (OS) and progression‐free survival (PFS) was then explored. RESULTS: A total of 43 patients were treated with first‐line ICI alone (58%) or in combination with chemotherapy (42%). A significant correlation was only found between the rectosigmoid SUV(ratio) and NLR (p = 0.0465). NLR >5.5 and LDH > 333.5 were associated with a worse OS (p = 0.033 and p = 0.009, respectively). The SII was associated with a worse PFS in patients treated with ICI alone (p = 0.033). None of the SUV(ratios) were significantly associated with OS or PFS, although a high left colon SUV(ratio) showed a trend toward a worse PFS. CONCLUSION: There was no significant correlation between [(18)F]FDG PET/CT uptake in different anatomical sites, and in the tumor, and systemic immune‐inflammatory indexes. The prognostic role of high left colon SUV(ratio) deserves further investigation. John Wiley & Sons Australia, Ltd 2023-07-13 /pmc/articles/PMC10447168/ /pubmed/37442801 http://dx.doi.org/10.1111/1759-7714.15032 Text en © 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Rizzo, Alessio
Cantale, Ornella
Mogavero, Andrea
Garetto, Lucia
Racca, Manuela
Venesio, Tiziana
Anpalakhan, Shobana
Novello, Silvia
Gregorc, Vanesa
Banna, Giuseppe Luigi
Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
title Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
title_full Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
title_fullStr Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
title_full_unstemmed Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
title_short Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
title_sort assessing the role of colonic and other anatomical sites uptake by [(18)f]fdg‐pet/ct and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447168/
https://www.ncbi.nlm.nih.gov/pubmed/37442801
http://dx.doi.org/10.1111/1759-7714.15032
work_keys_str_mv AT rizzoalessio assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors
AT cantaleornella assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors
AT mogaveroandrea assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors
AT garettolucia assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors
AT raccamanuela assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors
AT venesiotiziana assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors
AT anpalakhanshobana assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors
AT novellosilvia assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors
AT gregorcvanesa assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors
AT bannagiuseppeluigi assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors